Press ReleaseTelkomcel Holds TAIS 2025, Strengthens Commitment to Innovation and Digital Transformation DILI, Timor-Leste, March 5, 2025 /PRNewswire/ — Telkomcel has reaffirmed its commitment… CISION PRNewswireMarch 5, 2025
BusinessPress ReleaseBusiness Plan Contest "Photonics Challenge 2025" was Successfully Held in Hamamatsu City, the Center of the Optical Industry Three companies with outstanding optical technology – Beyond Optical Medical Technologies, Ectobrain Devices… CISION PRNewswireMarch 5, 2025
Press ReleaseVeeva CRM Pulse Improves Segmentation and Targeting with Brick-Level HCP Access Data for 21 Countries Delivered quarterly, CRM Pulse is generated from more than 500 million Veeva… CISION PRNewswireMarch 5, 2025
Press ReleaseCordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of Switzerland CordenPharma is making a record investment of >€1 billion over the next… CISION PRNewswireMarch 5, 2025
XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene's Commercial Presence in APAC – XPOVIO® is the first and only approved XPO1 inhibitor in Indonesia.… CISION PRNewswireMarch 5, 2025
Press ReleaseNew TXOne Networks OT/ICS Cybersecurity Report Details Growing Range of Risks Facing Companies as Digital Transformation Unfolds Globally Supply-chain vulnerabilities, aging infrastructure, patching difficulties and gaps in incident response demand urgent… CISION PRNewswireMarch 5, 2025
Global Terrorism Index 2025: Terrorism Spreads as Lone Wolf Attacks Dominate the West LONDON, March 5, 2025 /PRNewswire/ — The number of countries recording a… CISION PRNewswireMarch 5, 2025
XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene's Commercial Presence in APAC – XPOVIO® is the first and only approved XPO1 inhibitor in Indonesia.… CISION PRNewswireMarch 5, 2025
